 | • レポートコード：D0-MOR-AP0311 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、凍結手術装置の世界市場について調査・分析した資料で、凍結手術装置の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The cryosurgery devices market is expected to propel due to increasing disorders such as cardiovascular diseases and skin disorders. According to the World Health Organization, cardiovascular diseases are the leading cause of death, causing around 17.9 million death around the world. Furthermore, according to the data of Health and Safety Executive, in 2018, around 67 new cases were reported with work-related skin cancer in the United Kingdom. Hence, this emerges the need for treatment for these diseases. Also, development in the cryosurgery devices are expected to boost the market. In 2019, CSA Medical Inc. received European approval to market its product ‘Rejuven Air System’. It is a cryosurgical device that involves Metred Cryospray (liquid nitrogen) for the treatment of chronic bronchitis through bronchoscopic surgery. Thus, these factors are expected to boost the cryosurgery devices market.
Key Market Trends
Oncology Disorder Segment is Expected to Hold a Major Share in the Cryosurgery Devices Market
The oncology segment is expected to hold a major share in the cryosurgery devices market owing to the higher prevalence of cancer and rising preference towards minimally invasive surgery. According to the World Health Organization, the burden of cancer in 2018 was around 18.1 million cases globally. It is the second leading cause of death worldwide, causing around 9.6 million deaths according to the above-mentioned source.
Furthermore, cryoablation has been observed to be very effective in the treatment of breast carcinomas over the percutaneous ablation method. According to the World Health Organization, in 2018, lung and breast cancer are the most prevalent and approximately 2.1 million were diagnosed with it. Therefore, the aforementioned factors are expected to impact positively on the cryosurgery devices market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to be a dominant region for the studied market owing to the increasing burden of chronic disorders and the presence of product approvals. According to the National Cancer Institutes, in 2018, approximately 1.74 million were diagnosed with cancer in the United States. Furthermore, in 2019, the US FDA approved two cryosurgical devices ‘ CryoTouch’ and ‘CryoLab’ developed by Cryoconcepts. Cryotouch is a portable device that delivers cryogen to the targeted lesions while the cryolab is involved in high volume surgeries. These have been approved for 23 indications. Hence, such factors are expected to drive the cryosurgery market in North America.
Competitive Landscape
Some of the companies which are currently dominating the market are Harvard Bioscience Inc., AtriCure Inc., Brymill Cryogenic Systems, Cardinal Health, CryoConcepts, Cortex Technology, Bovie, and Cooper Surgical
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Diseases
4.2.2 Rising Preference for Minimally Invasive Surgeries
4.3 Market Restraints
4.3.1 Stringent Regulatory Guidelines and Reimbursement Issues
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Tissue Contact Probes
5.1.2 Tissue Spray Probes
5.1.3 Epidermal & Subcutaneous Cryoablation Devices
5.2 By Application
5.2.1 Surgeries
5.2.1.1 Oncology
5.2.1.2 Cardiology
5.2.1.3 Dermatology
5.2.1.4 Other
5.2.2 Pain Management
5.2.3 Recovery,Health and Beauty
5.3 By End User
5.3.1 Hospital
5.3.2 Cryotherapy Centre
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ArtiCure Inc.
6.1.2 Bovie
6.1.3 Brymill Cryogenic Systems
6.1.4 BVM Medical
6.1.5 Cardinal Health
6.1.6 CryoConcepts
6.1.7 Cortex Technology
6.1.8 Cooper Surgical
6.1.9 Harvard Bioscience Inc.
6.1.10 Premier Medical Co.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS